The spectrum of orbital Rosai-Dorfman disease

Yasaman Mohadjer, John B. Holds, Jack Rootman, Mathew W. Wilson, James W. Gigantelli, Philip L. Custer

Research output: Contribution to journalArticlepeer-review

37 Scopus citations


PURPOSE: To describe the spectrum and treatment of orbital Rosai-Dorfman disease and to review previously documented cases. METHODS: Retrospective, interventional case series of seven patients and literature review. RESULTS: Each patient with Rosai-Dorfman disease had unique disease expression requiring aggressive therapy, such as chemotherapy, radiation, and/or surgical excision. One systemically aggressive case presented with intraocular and choroidal invasion, a previously unreported finding. Response to therapy was variable and unpredictable. CONCLUSIONS: Rosai-Dorfman disease, although historically described as benign and self-limiting, may cause significant morbidity and mortality involving multiple organ systems. Available treatment options may not control the disease. Further research and long-term clinical correlation is necessary.

Original languageEnglish
Pages (from-to)163-168
Number of pages6
JournalOphthalmic plastic and reconstructive surgery
Issue number3
StatePublished - May 2006


Dive into the research topics of 'The spectrum of orbital Rosai-Dorfman disease'. Together they form a unique fingerprint.

Cite this